The purpose of this sco** review was to examine the science related to non-
pharmacological interventions designed to slow decline for older adults with Mild Cognitive …

Despite steadfast interest in the use of arts therapies (ATs) with individuals who have
dementia of the Alzheimer's type (DAT), a systematic review of the literature has not been …

Background Alzheimer's disease is characterized by amyloid-beta plaques, neurofibrillary
tangles, gliosis, and neuronal loss. Solanezumab, a humanized monoclonal antibody …

BackgroundA recent Cochrane review of reality orientation therapy identified the need for
large, well-designed, multi-centre trials. AimsTo test the hypothesis that cognitive stimulation …

Objectives Deprescribing has been proposed as a way to reduce polypharmacy in frail older
people. We aimed to reduce the number of medicines consumed by people living in …

Background: Parkinson's disease (PD) is a neurodegenerative disorder associated with
caregiver burden. Higher rates of burden are associated with adverse outcomes for …

Importance Parkinson disease and related disorders (PDRD) have consequences for quality
of life (QoL) and are the 14th leading cause of death in the United States. Despite growing …

Objectives: People with dementia (PwD) require an increasing degree of assistance with
activities of daily living (ADLs), and dependency may negatively impact on their well-being …

Background Cognitive training can potentially prevent cognitive decline. However, the
results of recent studies using semi-immersive virtual reality (VR)-assisted cognitive training …

Background Experiencing anxiety and depression is very common in people living with
dementia and mild cognitive impairment (MCI). There is uncertainty about the best treatment …